A method for recombinantly expressing and producing human thymosin in yeast
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 冯鹏波
- Publication Date
- 2016-07-06
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of genetic engineering, in particular to a method for producing human thymosin through recombinant expression of yeast. Background technique
[0002] Peptides have a very important and irreplaceable regulatory effect on the human body, which involves almost all physiological activities of the human body. For the immune system of the human body, peptides, especially thymosin or thymosins, are more important and direct. Thymosin is an immune drug that was applied earlier (Goldstein AL. 2007. History of the discovery of the thymosins. AnnNY Acad Sci. 1112: 1-13). Thymosin is secreted by thymus epithelial cells, a class of polypeptide hormone mixture containing more than 40 components, first discovered by Goldstein et al. in 1966 from fetal bovine thymus protein extract, and its level is closely related to the body's immune function. According to the positions of these polypeptides on the isoelectric focusing ...